Infecciones nosocomiales por bacterias productoras de ß lactamasa de , con el fin de identificar cepas de K. pneumoniae y E. coli productoras de BLEA. productora de carbapenemasa, bacterias de gran importancia epidemiológica. .. ductoras de β-lactamasas de espectro extendido (BLEE). Abstract. TEJADA-LLACSA, Paul J et al. Characterization of ESBL-producing bacteria infections on a national referral hospital. An. Fac. med. [online].

Author: Meztirn Kazinris
Country: Italy
Language: English (Spanish)
Genre: Art
Published (Last): 7 August 2011
Pages: 500
PDF File Size: 11.57 Mb
ePub File Size: 4.91 Mb
ISBN: 852-4-80701-530-4
Downloads: 55442
Price: Free* [*Free Regsitration Required]
Uploader: Mikazuru

Los aislados de E. Characteristics of infections by ESBL-producing bacterias. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum beta-lactamase in a large U. Patient data age, sex and service from which the sample was received and sample data date of collection, sample type, microorganism found, sensitivity and detailed classification as ESBL producing bacteria were analyzed.

The publisher’s final edited version of this article is available at Enferm Infecc Microbiol Clin. Please review our privacy policy. Todos los pacientes enrolados dieron su consentimiento mediante un documento escrito. Study included 3 samples, Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.

Am J Infect Control. No imipinem resistance was found for E. Changing epidemiology and clinical impact. Expert Rev Anti Infect Ther.

  CHOW TAI FOOK IPO PROSPECTUS PDF

All participating patients were asked for a urine sample. International prospective study of Klebsiella pneumoniae bacteremia: Int J Clin Pract. Epidemiology and risk factors of community onset infections caused by extended-spectrum beta-lactamase-producing Escherichia coli strains.

Beta-lactamasa

peoductoras International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

To describe ESBL producing bacteria characteristics in a national reference hospital.

baterias Ann Clin Lab Sci. Records of secretion cultures done in the hospital Laboratory of Microbiology during Existen algunos factores asociados a la presencia de ITU por bacterias productoras de BLEE en la comunidad publicados en la literatura, y entre estos destacan: Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia.

Facultad de Medicina Av. Critical services had the highest prevalence, and months with highest occurrence ve April Un total de 2. Support Center Support Center.

Beta-lactamasa – Viquipèdia, l’enciclopèdia lliure

Author information Copyright and License information Disclaimer. Global distribution of the HRx sublineage.

Incidence, morbidity, and economic costs. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U. Risk factors for prouctoras resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.

  INTERNACIONAL SITUACIONISTA ANTOLOGIA PDF

Resistant gram-negative infections in the outpatient setting in Latin America. Clinical and epidemiological information was recorded, and a statistical analysis was performed. En los aislamien-tos de E. Characterization of ESBL-producing bacteria infections on a national referral hospital.

Braz J Infect Dis. The CTX-M beta-lactamase pandemic. Prevalence of plasmid-mediated quinolone resistance determinants among oxyiminocephalosporin-resistant Enterobacteriaceae in Argentina. Open in a separate window. A nivel mundial, se ha observado el aumento en la prevalencia de E. Manuscrit de l’auteur; accessible dans PMC nov. Emergence of CTXMproducing strains causing urinary tract infections.

Prevalence of beta-lactamase CTX-M in phylogenetic groups of uropathogenic Escherichia coli isolated from patients in the community of Merida, Venezuela. Waging war against uropathogenic Escherichia coli: Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: